Schedule 13G ownership disclosure

EVOKE PHARMA INC

Security class unavailable · CUSIP: 30049G104

Event date: 2021-01-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-21-001011
Form type
SC 13G
Filer
Evoke Pharma Inc
CIK
CIK 1403708
Filed
Jan 20, 2021
Reporting period
Jan 14, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub